Rasagiline
CAS 136236-51-6
Overview
Rasagiline is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H
Anant Labs manufacture and furnish high quality Rasagiline impurities for global markets. Our Rasagiline EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS136236-51-6
Mol. FormulaC12H13N
Mol. Weight171.243 g/mol
IUPAC(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
SMILESC#CCN[C@@H]1CCC2=CC=CC=C12
InChIInChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1
InChI KeyRUOKEQAAGRXIBM-GFCCVEGCSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
rasagiline136236-51-6(R)-N-2-Propynyl-1-indanamineTV-1030Rasagilina(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amineNSC-759639(1R)-N-propargylindan-1-amine003N66TS6T(R)-Indan-1-yl-prop-2-ynyl-amine
